Opioids, Honestly: Dependence, Tolerance, and Staying Safe

One system, three jobs

Opioids relieve pain by activating the same receptors your body’s own endorphins use. But evolution assigned that receptor system three jobs at once: it dampens pain, it regulates breathing, and it marks experiences as rewarding. Every opioid effect — wanted and unwanted — flows from that triple assignment. Pain relief is the target; slowed breathing is the overdose mechanism; and the reward signal is why a drug prescribed for a knee can end up mattering to the brain far beyond the knee.

This is not an argument that opioids are always wrong. For severe acute pain, after surgery and major injury, at the end of life, and in cancer care they remain essential tools. The CDC’s 2022 guideline is more precise than its reputation: it does not ban opioids — it places them late in the ladder for chronic non-cancer pain, after non-opioid options have had a fair trial, and it asks prescribers to start low, reassess often, and pair every prescription with safety planning. The evidence behind that placement is direct: in the year-long SPACE trial, opioids performed no better than non-opioid medications for chronic back and arthritis pain — with more side effects.

Dependence is physiology, not a diagnosis

Take opioids regularly for a few weeks and the body adapts — receptor systems recalibrate around the drug’s presence. That adaptation is physical dependence, and it happens to essentially everyone on sustained therapy, the same way the body adapts to blood pressure medication or antidepressants. It means only one thing: stopping suddenly will cause withdrawal — muscle aches, sweating, insomnia, restlessness, diarrhea, anxiety. Unpleasant, temporary, and not dangerous in itself for most adults.

Opioid use disorder is a different thing entirely: a medical condition marked by loss of control, craving, and continued use despite harm. Most people prescribed opioids for pain do not develop it. Keeping the two ideas separate matters in both directions — withdrawal after a taper does not mean you were addicted, and a use disorder, when it does develop, is a treatable illness rather than a character verdict. Effective treatments exist (buprenorphine, methadone, naltrexone, plus behavioral support), and the SAMHSA National Helpline — 1-800-662-HELP (4357) — is a free, confidential, 24/7 starting point for anyone, including family members.

Tolerance, and the trap at the end of it

Tolerance is dependence’s cousin: over time the same dose produces less effect, which invites escalation. Two facts make this dangerous. First, tolerance to pain relief and euphoria rises faster than tolerance to respiratory depression — so the breathing margin quietly narrows as doses climb. Second, tolerance drops after a break: after detox, incarceration, or a successful taper, the dose a person used to handle can now stop their breathing. Returning to a previous dose after lost tolerance is one of the deadliest patterns in overdose data — and the reason the CDC specifically flags people coming off tapers for naloxone.

There is one more twist worth knowing by name: opioid-induced hyperalgesia. In some people on long-term opioids, the exposure itself sensitizes the pain system — pain spreads, light touch starts to hurt, and escalating doses chase a target the medication is helping to move. When pain keeps rising despite rising doses, that pattern is not failure or faking; it is a recognized pharmacological phenomenon, and the evidence-based response is a supervised taper plus non-opioid treatments, not a bigger prescription.

The combinations that kill

Overdose is rarely one drug. The FDA requires its most serious warning — a boxed warning — on opioids and benzodiazepines (alprazolam, lorazepam, diazepam) precisely because the combination suppresses breathing through converging pathways, and CDC data show most opioid-involved overdose deaths involve multiple substances. Alcohol, sleep medications, and the gabapentinoids (gabapentin, pregabalin) add to the same pile. If you take opioids and anything sedating — prescribed or not — that combination deserves to be named out loud with your prescriber and pharmacist, not discovered in an emergency.

Naloxone (Narcan and generics) is the antidote: an opioid blocker that restores breathing within minutes, available without a prescription in all 50 states, simple enough for a friend or family member to use, and harmless if given to someone who turns out not to have opioids on board. The CDC guideline says clinicians should offer it when prescribing opioids — especially with sedative combinations, higher doses, a history of substance use disorder or overdose, sleep-disordered breathing, or after tolerance has dropped — and recommends teaching household members. If opioids live in your home, naloxone should too. That is not pessimism; it is the same logic as owning a fire extinguisher.

Storage, disposal, and the medicine cabinet

Most diverted prescription opioids do not come from strangers — they come from the medicine cabinets of friends and relatives. The storage rules are unglamorous and real: locked or at least out of casual reach, away from children, teens, and visitors; original containers; a rough count kept. For disposal, DEA Take Back days and year-round drop boxes at pharmacies and police stations are the safest route; the FDA’s flush list exists for the most dangerous medications when no take-back option is available. And the leftover principle: do not keep unused opioids “just in case.” Much of the crisis began in leftover supplies.

If you’ve been on them for years

Long-term opioids can be tapered successfully — gradually, and with support. Guidelines explicitly warn against rapid or forced tapers: they can trigger uncontrolled pain, severe withdrawal, depression, and overdose when a person returns to a previous dose after losing tolerance. A well-run taper goes slowly enough for the nervous system to readapt, and it works best paired with the rest of the toolkit — movement-based care, non-opioid medications where they fit, and behavioral support for the fear that understandably comes with changing a long-standing plan. If stopping feels unmanageable, that is clinical information, not failure — and it is exactly what treatment exists for. SAMHSA’s helpline is 1-800-662-HELP (4357), free and confidential, any hour. This page describes; decisions about your medications belong to you and your care team.